Potential anticancer agents. 16. Methotrexate analogues with a modified peptide side chain. 1978

D C Suster, and E Tărnăuceanu, and D Ionescu, and V Dobre, and I Niculescu-Duvăz

Nine analogues of methotrexate, in which the side chain is modified by replacement of the terminal glutamyl moiety with other amino acids, were synthesized from 2,4-diamino-6-(chloromethyl)pteridine. None of these compounds exhibited significant activity against L1210.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D002279 Carcinoma 256, Walker A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed) Carcinosarcoma 256, Walker,Walker Carcinoma 256,Walker Carcinosarcoma 256
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

D C Suster, and E Tărnăuceanu, and D Ionescu, and V Dobre, and I Niculescu-Duvăz
April 1987, Journal of medicinal chemistry,
D C Suster, and E Tărnăuceanu, and D Ionescu, and V Dobre, and I Niculescu-Duvăz
April 2014, Bioorganic & medicinal chemistry letters,
D C Suster, and E Tărnăuceanu, and D Ionescu, and V Dobre, and I Niculescu-Duvăz
October 2009, Biochemical and biophysical research communications,
D C Suster, and E Tărnăuceanu, and D Ionescu, and V Dobre, and I Niculescu-Duvăz
December 1982, Journal of medicinal chemistry,
D C Suster, and E Tărnăuceanu, and D Ionescu, and V Dobre, and I Niculescu-Duvăz
March 2013, Anti-cancer agents in medicinal chemistry,
D C Suster, and E Tărnăuceanu, and D Ionescu, and V Dobre, and I Niculescu-Duvăz
September 2010, Medicinal research reviews,
D C Suster, and E Tărnăuceanu, and D Ionescu, and V Dobre, and I Niculescu-Duvăz
December 2011, ChemMedChem,
D C Suster, and E Tărnăuceanu, and D Ionescu, and V Dobre, and I Niculescu-Duvăz
August 1981, Journal of pharmaceutical sciences,
D C Suster, and E Tărnăuceanu, and D Ionescu, and V Dobre, and I Niculescu-Duvăz
December 1981, Journal of medicinal chemistry,
D C Suster, and E Tărnăuceanu, and D Ionescu, and V Dobre, and I Niculescu-Duvăz
October 2007, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!